BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 0 shares.
BG Medicine Stock Performance
BG Medicine Company Profile
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Read More
- Five stocks we like better than BG Medicine
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- The Significance of Brokerage Rankings in Stock Selection
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
